Highlights:- Total Income in Q3 FY23 at Rs. 140.12 crore, up 14.4% from Rs. 122.5 crore in Q3 FY22 During the year,…
Acquisition funded from Internal accruals; Expects turnover of Rs. 150 crore in next 3 years Highlights:- Investment in Cephalosporin plant…
To soon enter the EU markets with its Dermatology, Gastro and Pain Management products and expand gradually Highlights:- · EU permission will increase…